Clinical Trial

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

Study acronym: SC-Het-GM-CCS
Recruiting
View on ClinicalTrials.gov →
Summary
Advances in medical care have significantly improved survival among children with cancer. In China, the 5-year survival rate has reached 71.9%. Despite these improvements, many survivors continue to experience multiple co-occurring symptoms, such as fatigue, pain, sleep disturbance, and depression, which may adversely affect their quality of life. These symptoms often occur together as symptom clusters and may reflect shared underlying biological mechanisms. This study aims to characterize symptom clusters among childhood cancer survivors and to explore their potential biological basis. Participants will complete questionnaire assessments at multiple time points to evaluate symptom patterns and changes over time. In addition, stool samples will be collected to analyze gut microbiota composition and metabolite profiles. The study will examine the associations between symptom clusters and gut microbiota-metabolite features. Findings from this study are expected to improve understanding of symptom burden in childhood cancer survivors and to provide evidence for the development of targeted symptom management strategies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-27.
Trial Details
NCT Number NCT07450872
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Collaborators: Fujian Maternity and Child Health Hospital, Jiangxi Province Children's Hospital
Conditions Cancer, Glioma, Leukemia (Both ALL and AML)
Enrollment 600 participants
Start Date 2026-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-05